SNYR Stock Analysis: Buy, Sell, or Hold?
SNYR - Synergy CHC Corp. Common Stock
$0.29
0.01 (4.37%)
▲
5d:
-26.58%
30d:
-43.44%
90d:
-82.41%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 21, 2026
4d
Get Alerted When SNYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called SNYR this week
67% bullish • 2 bearish
67% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SNYR is down 26.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SNYR is down 26.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.13
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$2.56
88.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNYR is currently trading at $0.29, which is considered oversold relative to its 30-day fair value range of $0.31 to $0.57. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.6) compared to its historical average (4.2). Remarkably, the market is currently pricing in an annual earnings decline of 48.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.45. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: SNYR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.25 (+2080.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.45. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: SNYR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.25 (+2080.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.31 -
$0.57
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.4%)
- BULLISH: Trading 2080.0% below Wall St target ($6.25)
- WARNING: Recommendation downgraded due to -26.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.31 -
$0.57
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.27
Resistance Level
$0.45
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.57
Wall Street Target
$6.25
(+2080.0%)
Revenue Growth (YoY)
-41.0%
Earnings Growth (YoY)
-90.6%
Profit Margin
-40.6%
Valuation Discount vs History
-48.4% cheaper
PE vs Historical
0.6 vs 4.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-48.4%
(market-implied from PE analysis)
1-Year Target
$0.26
(-10%)
2-Year Target
$0.23
(-19%)
3-Year Target
$0.21
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1→4)
$1.55
(+439%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 288.5%)
$37.62
(+13020%)
Base:
(SPY PE: 0.6, Growth: 288.5%)
$0.97
(+238%)
Bear:
(PE: 0.5, Growth: 288.5%)
$0.82
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.6 to 4.2
Stabilization Target:
$2.12
(+639.8%)
PE Expansion Potential:
+639.8%
Share & Embed Analysis
Last updated: May 16, 2026 2:21 AM ET
Data refreshes hourly during market hours. Next update: 3:21 AM
Data refreshes hourly during market hours. Next update: 3:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$959 | 53 HOLD |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$245 | 63 BUY |
|
COR
Cencora Inc. |
BUY
17 analysts |
$365 | 58 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$87 | 55 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
